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Biofilm forming capacity and antibiotic susceptibility 
of Staphylococcus spp. with the icaA/icaD/bap genotype 




Bacterial biofilm is an exopolysaccharide matrix that is produced by bacteria while they adhere on abiotic or biotic surfaces. The 
bacteria living in this matrix are more resistant to antibiotics than planctonic bacteria. The biofilm formation property of  the bacteria 
is determined by genes; and this is related to virulence of  the microorganism. In ophthalmology, biofilms form especially on abiotic 
surfaces such as silicon tubes, contact lenses, intraocular lenses etc. 
Aim
Our aim was to investigate genotypic and phenotypic structures of  biofilms that are produced by Staphylococcus spp., which was obtained 
from  the eyes of  diabetic patients and determine the effect on antibiotic susceptibility.
Methods
The study group was comprised with 83 isolates  from  diabetic patients and 21 isolates from non-diabetic patients. Presumptive  isolates 
were detected and confirmed by a microbial identification system VITEK II. Automated EcoRI Ribotyping was performed.  Biofilm 
production was detected by Congo Red Agar Plate and Microtiter Plate Assay. Disc diffusion method was used for  determination of  
antibiotic susceptibility of   isolates. 
Results
Out of  the 83 isolates from diabetic patients, 25 were weakly (30%), 20 were moderately (24%), and 25 were strongly (30%) biofilm 
positive. Seven isolates of  S. aureus, 11 isolates of  S.epidermidis, 2 isolates of  S. warneri, 3 isolates of  S.hominis, and 2 isolates of  
S.lugdunensis were identified as strong biofilm producers. Out of  the 83 Staphylococcus isolates, 37 were cefuroxime, 18 ciprofloxacin, 11 
vancomycin, 12 gatifloxacin, and 18 moxifloxacin resistant. In total, 37 strains were resistant to three or more antibiotics.  There was 
a statistically significant relation between biofilm formation and multidrug resistance (against three or more antibiotics,p<0.001).  In 
nondiabetic patients, 15(71%) isolates  were non adherent or weakly adherent, and 2(10%) were strongly adherent biofilm positive. 
Conclusion
In conclusion, bacterial conjunctival flora of  patients with diabetes is likely to produce biofilm. Biofilm formation is associated with 
multidrug rsistance in patients with diabetes.  
Keywords: Diabetes; biofilm; Staphylococcus spp.; antibiotic resistance; ocular surface
Introduction
The ocular surface has a number of  defense mechanisms 
for the prevention of  ocular infections. Protein constituents 
in tears (lysozyme, immunoglobulins, lactoferrin) as well 
as bacterial flora of  the ocular surface have a major role 
in  restricting the growth of  bacterial species1. However, 
sources of  many ocular infections, especially post-operative 
ones, are ocular flora members. For example, coagulase 
negative Staphylococci (CoNS) are by far the most isolated 
microorganisms from post-operative endophthalmitis2-4.  
Diseases that break down immunity such as diabetes 
mellitus (DM), acquired immunodeficiency syndrome 
(AIDS) and/or other systemic diseases may contribute 
to the occurrence of  infections. In particular, DM affects 
cell mediated immunity and also lacrimal secretions5,6. 
Under such circumstances, flora gain virulence, which 
can include biofilm production properties or antibiotic 
resistance. One of  the main virulence factors for 
Staphylococci spp. predominantly found in the ocular flora 
is biofilm production. Biofilms, whose syntheses are 
controlled by the intercellular  adhesion  (ica) genes, are 
non-homogeneous collections of  bacteria which are 
bound together by an excreted matrix7-9. The enzyme 
N-acetylglucosaminyltransferase synthesizes polysaccharide 
intercellular adhesion (PIA), from UDP-N-acetylglucosamine 
in vitro that is encoded by t h e  i c a  locus and by the 
coexpression of  icaA with icaD genes9. Biofilm formation 
of  Staphylococci, which was isolated from infected eyes, has 
been reported previously10,11. However, to our knowledge, 
this study is the first to show biofilm formation and genetic 
analysis of  biofilms of  Staphylococcus  spp. that are isolated 
from the healthy conjunctiva of  patients with diabetes. 
In this study we investigated genotypic and phenotypic 
structures of  biofilm which are produced by Staphylococcus 
spp. and the effect of  biofilms on antibiotic susceptibility.
Methods 
Subjects
This study is a retrospective study. Isolates in this study were 
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obtained from  previous studies which  had been stored at 
– 80 C. Purification was done for this study. Eighty three 
isolates  were obtained from 50 eyes of  d iabet ic  patients 
(24 female, 26 male; age range: 50-88 years) with at least 
10 years duration of  Type II DM and without any ocular 
infection or allergic symptoms, and also 21 isolates of   38 
eyes of  non-diabetic patients (19 female, 19 male; age range: 
47-89 years). The study followed the principles of  the 
Declaration of  Helsinki. Sampling technique is explained 
elsewhere.12
Bacterial identification  
The swabs obtained were inoculated on to mannitol salt, 
nutrient and blood agar  plates. The incubation temperature 
and duration was 37oC and 24-48 hours respectively. Growing 
colonies were inoculated using the same media one by one for 
purification. Isolates that had been obtained from plates 
were identified using conventional (Gram stain, catalase, 
oxidase, coagulase, and DNAase reaction) and molecular 
microbiological methods.  The strains were further identified 
with VITEK II system (BioMerieux, Durham, NC, USA) 
according to the manual of  manufacturer. The identification 
ability of  these systems depends upon the number and 
diversity of  bacteria in the databases.
DuPont Qualicon RiboPrinter® Microbial  Characterization 
System (Oxoid, Hampshire, UK) and the standard EcoRI 
DNA preparation kit were used for Automated EcoRI 
Ribotyping according to the manufacturer’s guides. The 
reference DuPont identification database DUP2003 was 
used for comparison of  ribotype profiles.  Each isolate 
was identified when there was a similarity ≥0.85 
between the corresponding pattern and the matching pattern 
of  the DuPont identification Library. The ribogroups were 
made up of  the isolates automatically by the RiboPrinter™ 
according to the the matching similarity of  the ribotype 
patterns. The generated Finger Printing II software 
was used to analyse Riboprinter® and a dendrogram was 
created  according to Unweighted Pair Group Method using 
arithmetic Averages (UPGMA) and Pearson correlation 
coefficients (optimization 1.56%). Strains were stored in 
15% glycerol and at –80oC. Working cultures were stored at 
5
o
C and transferred periodically.
Biofilm formation  
Congo red agar (CRA) method: Biofilm formation in 
Staphylococcus strains was detected by growth on congo red 
agar (CRA) plates13. CRA plates that were inoculated  were 
incubated for 24 hours at 37oC.  Then, they were stored at 
room temperature for 48 hours. Appearance  of  the rough 
black colonies indicates  the slime producing strains of  
coagulase-negative Staphylococcus. Microtiter plate assay (MPA): 
A microtiter assay was used to detect biofilm production 
as previously described14. Staphylococcus strains were added 
into 10 ml of  tryptic soy broth (TSB) with 0.25% glucose. 
Then incubated f o r  2 4  h o u r s  at 37°C.Cultures were 
diluted at 1:100, diluted cultures (200 μl) per well were 
distributed into 96 well polystyrene microtiter plates and 
under aerobic conditions incubation was done at 37°C for 
24 hours. After incubation, they were washed with sterile 
phosphate buffered solution (PBS) twice, fixed in ethanol 
(99%) for 15 minutes, and washed again with PBS. Then 
200μl of  2% crystal violet per well was used to stain the 
plates for 5 minutes. Excess stain was washed out and  the 
plates were left to dry. The bond between the dye and the 
adherent cells was broken  with the use of  160 ml of  33% 
(v/v) glacial acetic acid. The optic densitometry (OD) was 
measured at 570 nm by using an automated microplate 
reader. The reading was done before glacial acetic acid 
addition, as in standard microtiter plate, and after glacial 
acetic acid addition14. Classification of  the results provided 
by the microtiter-plate test according to  Christensen et al 
has three categories15. However Stepeanovic et al. modified 
the classification14. Strains were classified as follows: OD ≤ 
ODc non-adherent, ODc < OD ≤ 2xODc weakly adherent, 
2xODc < OD ≤4xODc moderately adherent, 4xODc< 
OD strongly adherent.
All tests were performed  thrice and the mean of  the results 
was calculated.
Scanning electron microscopy analysis  
Scanning electron microscopy (SEM) (GeminiSem, Zeiss, 
Germany) biofilm specimens were prepared by fixation, 
staining, drying, and conductivity coating prior to imaging 
under high vacuum16. Firstly, bacteria were harvested and 
fixed in 2.5 % glutaraldehyde in 0.1 M cacodylate buffer for 2 
hours at room temperature, post fixed in 1% OsO4 (Osmium 
tetroxide) for 1 hour. Then bacteria were dehydrated in a 
series of  ethyl alcohol (30, 50, 70, 90 and 100 %), with each 
for 15 minutes. Samples were incubated in 100 % ethanol two 
times for 20 minutes. CO2 was used to dry them to a critical 
point. After that, according to standard procedures, they 
were prepared by sputtering gold film on them. Specimens 
were investigated with a Zeiss Ultra 50 Scanning electron 
microscope (SEM) operated at 5 kV accelerating tension.
Antibiotic sensitivity test  
Antibiotic sensitivity profile of  the CoNS against antibiotics, 
which are commonly used as eye drops, were assessed by 
the disc diffusion method with respect to the guidelines of  
Clinical Laboratory Standards Institute17. Discs contained 
the following antibacterial agents: gatifloxacin (5 µg), 
cefuroxime (30 µg), ceftazidime (30 µg), vancomycin (30 µg), 
gentamicin (10 µg), amikacin (30 µg), ciprofloxacin (5 µg), 
lomefloxacin (10 µg), moxifloxacin (5 µg), and methicillin 
(5 µg).
Detection of icaA, icaD, and bap genes encoding 
for biofilm  using  PCR
Firstly, bacterial lysates were prepared and DNA was 
extracted. After PCR-amplification was achieved , 
examination by electrophoresis on agarose gel was done   as 
described by Arciola et al18. Genomic DNA was extracted 
using Fermentas Gene JETTM Genomic DNA purification 
kit (Thermo Fisher Scientific, Waltham, MA, USA) based 
on  manufacturer recommendations. For detection of 
genes regarding biofilm formation, gene specific primers 
were used for PCR amplification of  DNA. The primer 
sequences and PCR length are shown  in Table 1. The 
reaction volume was 25 µl that contained  10X TaqBuffer 
(+KCl, –MgCl2), 25 mM MgCl2, 2.5 mM dNTP mix, 2.5 
mM forward primer, 2.5 mM reverse primer, Taq DNA 
polymerase (5 u/μl), nuclease- free distilled water, and 
template DNA. The PCR conditions for icaA and icaD 
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were the following:  5 minute initial denaturation at 94°C 
; 35 cycles of  94°C for 30 s, 55°C for 30 s, and 72°C 
for 60 s; and a five minute  final extension at 72°C19. PCR 
conditions for the bap gene were 94°C for 5 min; 35 cycles 
of  94°C for 30 s, 42°C for 30 s, and 72°C for 60 s; and a 
five minute  final extension at 72°C20.
Amplification products were analyzed using 1% agarose 
gel electrophoresis. A further nucleotide sequence of  the 
amplicon for bap gene was determined by sequencing. 
Amplicon that was purified from gel (Promega Wizard® Gel-
PCR Clean Up System, Promega BioSciences, LLC. San Luis 
Obispo, CA, USA) was sequenced by using DNA Beckman 
Coulter CEQ8000 Quick Start sequencing kit (Beckman 
Coulter, Fullerton, CA, USA). The data obtained from this 
sequencing procedure was compared with NCBI (National 
Center for Biotechnology Information) database by BLAST 
programme.  Our sequencing data showed 92 % similarity 
with Staphylococcus epidermidis biofilm-associated protein 
(bap) gene, complete cds (GenBank Accession Number 
DQ008306.1). 
Statistical analysis  
For statistical analysis, the Statistical Package for Social 
Sciences version 17 (IBM, Chicago, USA)  statistical 
programme was used. Pearson Chi-square was performed 
to compare qualitative data. In order to assess the relation 
between the parameters, Pearson correlation analysis 
was performed . P<0.01 and p<0.05 were considered 
statistically significant .
Results
In diabetic patients, 83 conjounctival  strains were isolated 
from  50 eyes, and 21 conjunctival  strains were isolated 
from  38 eyes of  non-diabetic subjects. The isolates were 
presumptively identified as Staphylococcus spp. According to 
conventional tests, isolates of  diabetic patients were members 
of  the species Staphylococcus epidermidis, Staphylococcus aureus, 
Staphylococcus warneri, Staphylococcus lugdunensis, Staphylococcus 
hominis, and Staphylococcus haemolyticus. Fig. 1 shows the 
RiboPrinter® Microbial Characterization System (Dupont 
Qualicon) results. S. epidermidis, S. aureus, S.  warneri, S. 
lugdunensis, S. hominis, and S. haemolyticus were detected 
with the RiboPrinter® system. Although these genotypic 
identification results were almost concordant  with those of  
VİTEC II results, they were detected  as S. epidermidis in 38, 
S. aureus in 8, S. warneri in 19, and other coagulase negative 
staphylococcus in the remaining 18 isolates. 
S. epidermidis were dominant among the isolates obtained 
from the conjunctiva of  healthy patients with diabetes (Fig 
2). From 17 eyes, 38 S. epidermidis conjunctival  strains were 
isolated.
It was observed that 25 (30%) out of  83 isolates were 
weakly positive, 20 (24%) were moderately positive, and 25 
(30%) were strongly positive, with the remaining 13 (16%) 
isolates biofilm negative with at least one of  the methods 
used for detection of  biofilm formation (Fig. 3).
According to conventional tests and the RiboPrinter® 
Microbial Characterization System, isolates of  non-diabetic 
subjects were members of  the species S. epidermidis, S. aureus, 
S. warneri, S. hominis, and S. saprophyticus (Fig. 2) . Fifteen (71%) 
out of  21 isolates were non-adherent or weakly adherent, 4 
(19%) were moderately adherent, and 2 (10%) were strongly 
adherent biofilm positives (Fig. 3). 
Fig. 1: Riboprinter® microbial characterization system 
(DupontQualıcon) results in diabetic patients showing 
ribotyping profiles of  the isolates S. epidermidis, S. aureus, 
S. warneri, S. lugdunensis, S. hominis and S. haemolyticus
Fig. 2: Isolation rate of strains in healthy and type II diabetic cohorts
Malawi Medical Journal 30 (4); 243-249 December 2018 Biofilm and ocular surface of diabetic patients 246
https://dx.doi.org/10.4314/mmj.v30i4.6 
The rate of  strong biofilm formation of S. aureus as the 
prominent pathogenic microorganism of  the flora in the 
non-diabetic group was 20%, whereas the rate in the diabetic 
group  was 88%. The examples of  weak and strong biofilm 
formation by S.epidermidis colonies of  diabetic patients are 
shown in Fig 4A and 4B in SEM microphotographs. Seven 
isolates of  S. aureus, 11 isolates of  S. epidermidis, 2 isolates 
of  S. warneri, 3 isolates of  S. hominis, a n d  2 isolates of  S. 
lugdunensis from diabetics were found to be strong biofilm 
producers (Fig. 3). 
The antibiogram study revealed that 5 isolates of  S. aureus, 
19 isolates of  S. epidermidis, 15 isolates of  S. warneri, and 9 
isolates of  S. lugdunensis in diabetic patients were resistant 
to methicillin (Fig. 5). Out of  83 Staphylococcus isolates, 37 
were cefuroxime resistant, 18 were ciprofloxacin resistant, 
9 were amikacin resistant, 11 w e r e  vancomycin resistant, 
12 w e r e  gatifloxacin resistant, 16 w e r e  lomefloxacin 
resistant, and 18 we r e  moxifloxacin resistant. There was 
no isolate resistance to gentamicin. In total, 37 strains (45%) 
were resistant to three or more antibiotics. Drug resistance 
against 6 or more antibiotics was detected in 11 (13%) 
isolates, against 7 or more in 3 (4%), and against 8 antibiotics 
in 1 (1%) (Fig. 5). The relation between biofilm formation 
and multidrug resistance (against three or more antibiotics) 
was statistically significant (p<0.001). In the biofilm positive 
coagulase negative staphylococcus strains, the resistance 
rate was high to methicillin (67%), cefuroxime (37%), 
and ceftazidime (41%), whereas the resistance rate was 
low against gentamicin (4%). I n  the biofilm negative 
S. epidermidis strains, the resistance rate was high to 
ciprofloxacin (14%) and the resistance rate was l o w  to 
methicillin (3%). Biofilm producing S. epidermidis strains 
showed  a significantly increased methicillin resistance 
(63%). Methicillin resistance was 50% in biofim-positive 
and 44% in biofilm-negative strains (Fig. 5). In non-diabetic 
subjects, 6 isolates were cefuroxime resistant, 8 were 
ceftazidime resistant, 5 were ciprofloxacin resistant, 2 were 
vancomycin resistant, 1 was gatifloxacin resistant, 3 were 
lomefloxacin resistant, and 4 were moxifloxacin resistant. 
There was no resistance to both gentamicin and amikacin. 
Only 1 isolate had resistance against 6 (5%) antibiotics. No 
resistance was detected against 7 antibiotics or more (Fig. 
5). 
Fig. 5: Antimicrobial resistance to antibiotics of biofilm-positive 
Staphyloccocus spp. strains in healthy and type II diabetic cohorts
All isolated strains from diabetic patients were positive for 
icaA and icaD. The biofilm-producing and non-producing 
Staphylococcus spp. had both genes, giving a 188-bp band 
for the icaA gene and a 198-bp band for the icaD gene 
(Fig. 6 A and B). The molecular weight marker kit was used 
to determine the size of  standard bands, then the image 
analyzer system designated  the expected lengths to the 
bands t h a t  w e r e  obtained by amplification of  the 
extracted DNA. 
DNA extracted from 8 S. aureus, 18 S. warneri, 5 S. hominis, 12 
S. lugdunensis, 1 S. haemolyticus, and 39 S. epidermidis isolates 
were tested for icaA, icaD detection , and the bap gene 
by PCR using gene-specific primers (Fig 6 C). All isolates 
had   icaA and icaD positivity, and one of  the tested isolates 
was found to be bap positive.  Sequencing was done 
for the bap gene. Sequencing of  this amplicon showed 
92% similarity with S. epidermidis biofilm-associated protein 
(bap) gene, complete cds (GenBank Accession Number 
DQ008306.1).
All of  the isolates of  non-diabetic subjects were icaD and 
icaA positive. No bap positivity was detected.
Fig. 3: Number of strains and their biofilm strength with at least 
one of the methods   in healthy and  type II diabetic cohorts:
Fig. 4: SEM microphotographs; A) A weak (S. epidermidis KA 
14.5) biofilm producer strains, B) A strong (S. epidermidis KA 15.8 
) biofilm producer strains from diabetic patients
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Fig. 6: PCR amplified product of  (A) icaA gene. M; pBR322 DNA/
AluI Marker (Fermentas) (B) icaD gene. M; pBR322 DNA/AluI 
Marker (Fermentas) and (C) bap gene. M; DirectLoad 1 kb DNA 
Ladder (Sigma-Aldrich).
Discussion
Coagulase negative staphylococci are types of  flora found 
in the eyelids, meibomian glands, and especially on the 
ocular surface. It has been shown that these bacteria enter 
the eye during and after intraocular surgery, which 
may cause endophthalmitis, a devastating complication 
of  operations4,21-23. However, this complication is rare 
because of  the equilibrium between host defense, bacterial 
virulence, and antibiotic resistance.  Recent studies show that 
one of  the major virulence factors for bacteria, especially 
for staphylococci, is biofilm production. Microorganisms, 
which produce biofilms are also more prone to develop 
resistance to antibiotics7,24,25.
The rate of  strong biofilm formation in diabetic patients was 
30%, whereas the rate is 10% in non-diabetic subjects. On 
the one hand, we found that, in diabetics, the rate of  strong 
biofilm formation of  S. aureus as the prominent pathogenic 
microorganism was 88% whereas it was 20% in the control 
group. This study may suggest that bacteria from the 
ocular surface in patients with diabetes are likely to produce 
biofilm. Moreover, non-biofilm producer strains are more 
susceptible to antibiotics than the biofilm producers. 
In previous studies, the rates for biofilm production of  
S. epidermidis were 34-74% in infected eyes and 18-46% in 
healthy conjunctivas according to CRA methods10,11,26,27. In 
this study, the biofilm production rate of  all Staphylococcus 
and all CoNS are 77% and 74%, respectively, according to 
CRA methods and 79% in diabetics. Our rate is higher 
than the rate found in previous studies in which healthy eyes 
were evaluated and similar to those with ocular infections, 
though our samples were taken from healthy eyes. This may 
be attributed to the presence of  diabetes in t h e  cohort, 
probably facilitating the rate of  biofilm production. 
Studies concerning biofilm production from healthy 
eyes are limited in literature. Suzuki et al. reported that 
their biofilm production rate for S. epidermidis was 46% 
and they noticed that all black colonies in the CRA were 
icaA positive26. Verdayes et al. also reported a  lower rate 
(18%) for biofilm production; however their rates for icaA 
positivity for biofilm positive isolates were 88% and icaD 
positivity were 100%27. In this study, both icaA and icaD 
positivity rates of  biofilm plus strains are 100%. In addition 
to the ica genes, we investigated isolates for the bap gene, 
which we detected in one isolate. Also in non-diabetics, the 
rates for icaA and icaD positivity in all isolates is 100% but 
no positivity for bap is detected.  Due to the small sample 
size of  control subjects in this study, it was not feasible to 
compare the results of  diabetic patients with the control 
subjects statistically. Therefore, we only presented the 
findings of  the healthy control subjects. 
We noticed a correlation between biofilm formation 
capacity and antibiotic resistance. We found there was no 
vancomycin resistance in non-biofilm producer strains; 
however, vancomycin resistance was found in 12 of  the 
biofilm producer strains. For fluoroquinolones, which are 
frequently used as eye drops, resistance was also similar. 
In diabetics, the number of  resistant strains in non-biofilm 
producers for ciprofloxacin was 5, lomefloxacin was 2, 
moxifloxacin was 1, and gatifloxacin was 0. These numbers 
for isolates in biofilm producer strains were 12, 15, 15, and 
12, respectively. In non-diabetic subjects, similar to the non-
biofilm producer strains of  diabetic patients, the number of  
resistant strains in biofilm producer strains for ciprofloxacin 
was 5, for lomefloxacin it was 3, for moxifloxacin it was 4, 
and for gatifloxacin it was 1. 
We found that biofilm producing strains are all susceptible 
to gentamicin. Multidrug resistance was found to be related 
to biofilm formation. Antibiotic susceptibility rates of  
biofilm producing strains from patients with diabetes 
have not been previously published. Catalanotti et al. 
reported that biofilm producing microorganisms, which 
were isolated from the conjunctiva of  soft contact lens 
users, had higher antibiotic resistance than non-biofilm 
producers10. They noticed that all S. epidermidis were 
susceptible to gentamicin, netilmicin, ofloxacin, neomycin, 
and kanamycin10.  Alabiad et al. showed the fluoroquinolone 
resistance of  conjunctival cultures to be 33% from patients 
who had undergone intravitreal injection28. Blanco et 
al. reported that staphylococci isolates from chronic 
conjunctivitis were highly susceptible to vancomycin 
and moxifloxacin29. Methicillin sensitive S. epidermidis had 
low susceptibility to ciprofloxacin and erythromycin. 
Methicillin resistant S. epidermidis was only susceptible to 
moxifloxacin and vancomycin29. However, these studies did 
not mention the biofilm states of  the isolates and whether 
these isolates were obtained from patients with diabetes 
or not. The relationship between biofilm formation and 
multidrug resistance has been reported previously26,31,32.
We have isolated non-biofilm producing strains which were 
icaA and icaD positive. Similar findings were reported from 
Hou et al previously, and they noted that the bacterial strains 
required genetic capability  for biofim production; it is not 
implied that the biofilms will  certainly form11.
Diabetes Mellitus (DM) is a systemic disease which 
damages cell- mediated immunity. Because of  diabetes, 
retinopathy may develop. DM may also cause cataract. 
Besides these diseases, DM may cause some changes on 
the ocular surface and tear film6. Thus, microbial flora of  
the ocular surface varies. There are studies on the ocular 
surface flora of  diabetic patients, which have shown that 
culture positivity and CoNS rates are higher in patients with 
diabetes; and the flora of  the conjunctiva in diabetic patients 
is different from non-diabetic patients33-35.  However, 
to the best of  our knowledge, biofilm capacity of  the 
ocular surface bacteria of  patients with diabetes has not 
been reported before. In order to reduce or inhibit biofilm 
production in diabetic patients, specific strategies have not 
been defined yet. During biofilm formation, the process of  
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bacterial attachment may be affected by species of  bacteria, 
the surface condition, environmental factors (presence of  
glucose, etc.), growth medium, and essential gene products36. 
Antibiotics inhibit biofilm formation in vitro when added 
into media at the same time as the microorganism, however 
the effect of  antibiotics is limited on preformed biofilm37. 
On the one hand, any agent that can change the viscoelastic 
property of  the biofilm, chelating agents (EDTA), and 
polyamines (norspermidine) is helpful in inhibiting biofilm 
formation38,39. Therefore, besides an adequate metabolic 
control of  glucose in diabetic patients, any measure 
targeting one of  these factors may be helpful in the future 
for controlling or inhibiting biofilm production.   
In this study, we report the staphylococcal characteristics 
of  the ocular flora. We found CoNS (90%) as a dominant 
group of  the staphylococcal flora, and the main member 
of  this group is S. epidermidis (45%). There are few studies 
about biofilm producing microorganisms that are isolated 
from patients’ bodies with diabetes except the eyes. 
Podbielska et al. reported that 59% of  S. aureus and 75% of  
S. epidermidis from f e e t  o f  d i a b e t i c  p a t i e n t s 
had produced biofilms.40 However, they did not mention 
the ica status of  the isolates. 
Conclusion
Bacterial conjunctival flora of  patients with diabetes may 
be  more likely to produce biofilms. Biofilm formation is 
associated with multidrug resistance. Further studies with 
larger control groups may improve our understanding 
of  biofilm formation and properties in diabetic patients. 
Patients with a long duration of  diabetes should  be 
evaluated carefully before planned surgery. It should be kept 
in mind that antibiotic resistance patterns may be vital for 
the success of  surgery.
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